305 related articles for article (PubMed ID: 19715979)
1. Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation.
Dandel M; Jasaityte R; Lehmkuhl H; Knosalla C; Hetzer R
Transplant Proc; 2009; 41(6):2585-8. PubMed ID: 19715979
[TBL] [Abstract][Full Text] [Related]
2. Preventing cardiac allograft vasculopathy: long-term beneficial effects of mycophenolate mofetil.
Kaczmarek I; Ertl B; Schmauss D; Sadoni S; Knez A; Daebritz S; Meiser B; Reichart B
J Heart Lung Transplant; 2006 May; 25(5):550-6. PubMed ID: 16678034
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients.
Hamour IM; Lyster HS; Burke MM; Rose ML; Banner NR
Transplantation; 2007 Mar; 83(5):570-6. PubMed ID: 17353776
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Mycophenolate Mofetil Acute Renal Rejection Study Group
Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
[TBL] [Abstract][Full Text] [Related]
5. Comparison between mycophenolate mofetil- and azathioprine-based immunosuppressions in clinical lung transplantation.
Zuckermann A; Klepetko W; Birsan T; Taghavi S; Artemiou O; Wisser W; Dekan G; Wolner E
J Heart Lung Transplant; 1999 May; 18(5):432-40. PubMed ID: 10363687
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
7. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
[TBL] [Abstract][Full Text] [Related]
8. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
10. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
Triemer HL; Pearson TC; Odom KL; Larsen CP
Clin Transplant; 2000 Aug; 14(4 Pt 2):413-20. PubMed ID: 10946781
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
[TBL] [Abstract][Full Text] [Related]
12. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
13. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272
[TBL] [Abstract][Full Text] [Related]
14. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ
Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
Sollinger HW
Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
[TBL] [Abstract][Full Text] [Related]
16. Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.
Zhu B; Liu Z; Wu C; Wang P; Wang X; Xu H
Transplant Proc; 2008 Sep; 40(7):2258-61. PubMed ID: 18790207
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
Sterneck M; Fischer L; Gahlemann C; Gundlach M; Rogiers X; Broelsch C
Ann Transplant; 2000; 5(1):43-6. PubMed ID: 10850611
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.
Celik MR; Lederer DJ; Wilt J; Eser D; Bacchetta M; D'Ovidio F; Sonett JR; Arcasoy SM
J Heart Lung Transplant; 2009 Jul; 28(7):697-703. PubMed ID: 19560698
[TBL] [Abstract][Full Text] [Related]
19. De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results.
Guethoff S; Stroeh K; Grinninger C; Koenig MA; Kleinert EC; Rieger A; Mayr T; von Ziegler F; Reichart B; Hagl C; Schramm R; Kaczmarek I; Meiser BM
J Heart Lung Transplant; 2015 May; 34(5):634-42. PubMed ID: 25701373
[TBL] [Abstract][Full Text] [Related]
20. Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation.
Oh JM; Wiland AM; Klassen DK; Weidle PJ; Bartlett ST
J Clin Pharmacol; 2001 Aug; 41(8):861-9. PubMed ID: 11504274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
